Updates on Endothelial Functions of Proangiogenic Prokineticin.
From the Biotechnology and Cell Signaling Laboratory (UMR 7242), CNRS-University of Strasbourg, Illkirch, France. nebigil@unistra.fr.
Canan G
CG
Nebigil
D000818:Animals; D002318:Cardiovascular Diseases / Q000378:metabolism / Q000503:physiopathology; D002454:Cell Differentiation; D002465:Cell Movement; D002478:Cells, Cultured; D003326:Coronary Circulation / Q000502:physiology*; D004730:Endothelium, Vascular / Q000378:metabolism* / Q000502:physiology*; D006801:Humans; D006973:Hypertension / Q000378:metabolism / Q000503:physiopathology; D007674:Kidney Diseases / Q000378:metabolism / Q000503:physiopathology; D051379:Mice; D008967:Molecular Biology; D032383:Myocytes, Cardiac / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled / Q000378:metabolism*; D018000:Receptors, Peptide / Q000378:metabolism*; D012079:Renal Circulation / Q000502:physiology; D012680:Sensitivity and Specificity
C470837:PROKR1 protein, human; C470838:PROKR2 protein, human; D043562:Receptors, G-Protein-Coupled; D018000:Receptors, Peptide